Literature DB >> 21301645

PURLs: Help for recurrent bacterial vaginosis.

Kohar Jones1, Bernard Ewigman.   

Abstract

Entities:  

Year:  2011        PMID： 21301645      PMCID： PMC3183959     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  7 in total

1.  Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study.

Authors:  Wang Ya; Cheryl Reifer; Larry E Miller
Journal:  Am J Obstet Gynecol       Date:  2010-08       Impact factor: 8.661

2.  Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.

Authors:  Kingsley Anukam; Emmanuel Osazuwa; Ijeoma Ahonkhai; Michael Ngwu; Gibson Osemene; Andrew W Bruce; Gregor Reid
Journal:  Microbes Infect       Date:  2006-03-29       Impact factor: 2.700

3.  Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data.

Authors:  Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Obstet Gynecol       Date:  2007-01       Impact factor: 7.661

Review 4.  Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.

Authors:  M R Joesoef; G P Schmid; S L Hillier
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

5.  High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.

Authors:  Catriona S Bradshaw; Anna N Morton; Jane Hocking; Suzanne M Garland; Margaret B Morris; Lorna M Moss; Leonie B Horvath; Irene Kuzevska; Christopher K Fairley
Journal:  J Infect Dis       Date:  2006-04-26       Impact factor: 5.226

6.  Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

Authors:  R Amsel; P A Totten; C A Spiegel; K C Chen; D Eschenbach; K K Holmes
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

Review 7.  Metronidazole is still the drug of choice for treatment of anaerobic infections.

Authors:  Sonja Löfmark; Charlotta Edlund; Carl Erik Nord
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.